RecruitingNCT06081231
Open-Source Artificial Pancreas System Use Among People With Type 1 Diabetes Mellitus in China
The Safety and Efficacy of Open-Source Artificial Pancreas System Among People With Type 1 Diabetes Mellitus in China
Sponsor
Third Affiliated Hospital, Sun Yat-Sen University
Enrollment
500 participants
Start Date
Jan 1, 2019
Study Type
OBSERVATIONAL
Conditions
Summary
This real-world observational study aims to reveal the current status of the open-source artificial pancreas system (APS) use among people with T1DM in China and assess the glycemic efficacy and potential related factors of the open-source APS.
Eligibility
Min Age: 3 YearsMax Age: 75 Years
Inclusion Criteria4
- diagnosed T1DM.
- Currently use open-source APS for at least 3 months.
- Willing and able to provide informed consent (or be a parent or other legally authorized representative) and to provide the data.
- reside in China.
Exclusion Criteria1
- None
Interventions
DEVICEopen-source APS;
a continuous glucose monitoring system, an insulin pump, and an intelligent algorithm.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06081231
Related Trials
Biomarkers of Acute Organ Injury in Pediatric Newly Diagnosed Type 1 Diabetes
NCT074838791 location
Physical Activity to Prevent and Treat Hyperglycemia From a Mistimed Bolus Insulin Dose
NCT066863291 location
Establishment of Screening Pathway for High-Risk Population of Type 1 Diabetes
NCT074684741 location
Clinical Study to Evaluate the Impact of the Accu-Chek SmartGuide CGM Solution on the Mean Change in Time in Range Compared With Self-Monitoring of Blood Glucose in Participants With Type 1 and Type 2 Diabetes Mellitus
NCT0670467214 locations
Characterization of Type 1 Diabetes Subgroup: An Artificial Intelligence Analysis of Clinical and Glucometric Features
NCT074618051 location